Past and current perspective on new therapeutic targets for Type-II diabetes
Pradip D Patil,1,* Umesh B Mahajan,1,* Kalpesh R Patil,2,* Sandip Chaudhari,1 Chandragouda R Patil,1 Yogeeta O Agrawal,3 Shreesh Ojha,4 Sameer N Goyal11Department of Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research, 2Department of Pharmacology, H. R. Pat...
Saved in:
Main Authors: | Patil PD (Author), Mahajan UB (Author), Patil KR (Author), Chaudhari S (Author), Patil CR (Author), Agrawal YO (Author), Ojha S (Author), Goyal SN (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quality-by-Design-Driven Nanostructured Lipid Scaffold of Apixaban: Optimization, Characterization, and Pharmacokinetic Evaluation
by: Kiran Patil, et al.
Published: (2024) -
Cardiovascular sympathetic functional status of controlled type II diabetes mellitus
by: P.P. Patil, et al.
Published: (2013) -
Therapeutic Potential and Pharmaceutical Development of Thymoquinone: A Multitargeted Molecule of Natural Origin
by: Sameer N. Goyal, et al.
Published: (2017) -
Research and clinical practice current scenario
by: Mallangouda S. Patil
Published: (2022) -
Current perspective on the role of insulin and glucagon in the pathogenesis and treatment of type 2 diabetes mellitus
by: Ojha A, et al.
Published: (2019)